Pegylated liposomal doxorubicin and gemcitabine in the front-line treatment of recurrent/metastatic breast cancer : a multicentre phase II study

2008

Pegylated liposomal doxorubicin and gemcitabine in the front-line treatment of recurrent/metastatic breast cancer: a multicentre phase II study

Keywords:

Correction
Source
Cite
Save
Machine Reading By IdeaReader

31

References

21

Citations